ClinConnect ClinConnect Logo
Search / Trial NCT03131596

Postoperative Intermittent Intrauterine Balloon Dilatation Therapy.

Launched by FU XING HOSPITAL, CAPITAL MEDICAL UNIVERSITY · Apr 24, 2017

Trial Information

Current as of May 08, 2025

Completed

Keywords

Intrauterine Adhesion Hysteroscopy Intrauterine Balloon Reformation Prevention

ClinConnect Summary

Patients

The patients will be recruited from the Hysteroscopy Center of the Fuxing Hospital, Beijing, China. Before the surgery all patients with suspected Asherman syndrome will undergo preoperative evaluations, including a detailed history of the menstrual pattern, any previous intrauterine surgery, and reproductive history, as well as trans-vaginal ultrasonography. The severity and extent of intrauterine adhesions will be scored according to a classification system recommended by the American Fertility Society (AFS) (1988 version). The inclusion criteria include \[1\] women aged 18-40 y...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. women aged 18-40 years;
  • 2. moderate to severe intrauterine adhesion (AFS score≥5);
  • 3. no previous history of hysteroscopic adhesiolysis in our hospital;
  • 4. written consent obtained
  • 5. agreement to have second-look and third-look hysteroscopy.
  • Exclusion Criteria:
  • 1. minimal adhesion (AFS score \<5);
  • 2. previous hysteroscopic adhesiolysis in our hospital.

About Fu Xing Hospital, Capital Medical University

Fu Xing Hospital, affiliated with Capital Medical University, is a leading medical institution dedicated to advancing healthcare through rigorous clinical research and innovative patient care. Renowned for its commitment to medical excellence, the hospital fosters a collaborative environment that integrates clinical practice, education, and research. With a focus on ethical standards and patient safety, Fu Xing Hospital actively engages in a diverse range of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. The institution's strong academic foundation and experienced research team contribute to its reputation as a trusted sponsor in the clinical trial landscape.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Tinchiu Li

Study Chair

Fuxing Hospital,Capital Medical University,China

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials